Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5589 ARTÍCULOS , VIENDO DEL 4306 AL 4320

Management of CLN1 Disease: International Clinical Consensus

Augustine EF, Adams HR, de Los Reyes E, Drago K, Frazier M, Guelbert N, Laine M, Levin T, Mink JW, Nickel M, Peifer D, Schulz A, Simonati A, Topcu M, Turunen JA, Williams R, Wirrell EC, King S.

Pediatr Neurol. 2021 Jul;120:38-51. doi: 10.1016/j.pediatrneurol.2021.04.002. Epub 2021 Apr 9.

Wernicke-Korsakoff syndrome despite no alcohol abuse: A summary of systematic reports

Oudman E, Wijnia JW, Oey MJ, van Dam M, Postma A.

J Neurol Sci. 2021 Jul 15;426:117482. doi: 10.1016/j.jns.2021.117482. Epub 2021 May 7.

Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids, a mimicker of malignancy: a case report and review of the literature

Zhuang E, Shane L, Ramezan N, Ismail AF, Vora NL.

J Med Case Rep. 2021 May 18;15(1):246. doi: 10.1186/s13256-021-02814-5.

PMM2-CDG

Lam C, Krasnewich DM.

2005 Aug 15 [updated 2021 May 20]. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews(®) [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2026.

Potassium channels and autism spectrum disorder: An overview

Cheng P, Qiu Z, Du Y.

Int J Dev Neurosci. 2021 Oct;81(6):479-491. doi: 10.1002/jdn.10123. Epub 2021 Jun 22.

Ataxin-2 gene: a powerful modulator of neurological disorders

Laffita-Mesa JM, Paucar M, Svenningsson P.

Curr Opin Neurol. 2021 Aug 1;34(4):578-588. doi: 10.1097/WCO.0000000000000959.

Autoimmune movement disorders with neuronal antibodies - an update

Balint B, Bhatia KP.

Curr Opin Neurol. 2021 Aug 1;34(4):565-571. doi: 10.1097/WCO.0000000000000956.

[A case of autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy]

Adachi H, Shiomi Y, Kimura A, Shimohata T, Yoneda Y, Kageyama Y.

Rinsho Shinkeigaku. 2021 Jun 29;61(6):401-404. doi: 10.5692/clinicalneurol.cn-001575. Epub 2021 May 20.

Clinical characterization and the improved molecular diagnosis of autosomal dominant cone-rod dystrophy in patients with SCA7

Zou X, Yao F, Li F, Wu S, Li H, Sun Z, Zhu T, Wei X, Li D, Sui R.

Mol Vis. 2021 May 7;27:221-232. eCollection 2021.

Acute relapse and poor immunization following COVID-19 vaccination in a rituximab-treated multiple sclerosis patient

Etemadifar M, Sigari AA, Sedaghat N, Salari M, Nouri H.

Hum Vaccin Immunother. 2021 Oct 3;17(10):3481-3483. doi: 10.1080/21645515.2021.1928463. Epub 2021 May 20.

Seizure as a presenting manifestation of Wernicke's encephalopathy induced by hyperemesis gravidarum

Ghosh R, Mandal A, Roy D, Chatterjee S, Ghosh MK, Dubey S, Lahiri D, Finsterer J, Ray BK.

J Family Med Prim Care. 2021 Jan;10(1):567-571. doi: 10.4103/jfmpc.jfmpc_1466_20. Epub 2021 Jan 30.

Results of a randomized double-blind study evaluating luvadaxistat in adults with Friedreich ataxia

Wang H, Norton J, Xu L, DeMartinis N, Sen R, Shah A, Farmer J, Lynch D.

Ann Clin Transl Neurol. 2021 Jun;8(6):1343-1352. doi: 10.1002/acn3.51373. Epub 2021 May 20.

Spinocerebellar ataxia clinical trials: opportunities and challenges

Brooker SM, Edamakanti CR, Akasha SM, Kuo SH, Opal P.

Ann Clin Transl Neurol. 2021 Jul;8(7):1543-1556. doi: 10.1002/acn3.51370. Epub 2021 May 21.

The rare and the common: An Austrian DRPLA family harboring the European haplotype

Amprosi M, Zech M, Lichtner P, Eckstein G, Unterberger I, Eigentler A, Indelicato E, Puttinger G, Nachbauer W, Boesch S.

Parkinsonism Relat Disord. 2021 Jun;87:119-121. doi: 10.1016/j.parkreldis.2021.04.024. Epub 2021 May 12.

Plastin 3 in health and disease: a matter of balance

Wolff L, Strathmann EA, Müller I, Mählich D, Veltman C, Niehoff A, Wirth B.

Cell Mol Life Sci. 2021 Jul;78(13):5275-5301. doi: 10.1007/s00018-021-03843-5. Epub 2021 May 23.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias